User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: A Delphi consensus statement

Primary tabs

Ninane, Vincent Brusselle, Guy G. Louis, Renaud Dupont, Lieven Liistro, Giuseppe [UCL] Vincken, Walter

Objectives: The study aimed to assess usage of inhalation devices in asthma and chronic obstructive pulmonary disease (COPD). Methods: In this two-round Delphi survey, 50 experts in asthma and COPD completed a 13-item, Internet-based, self-administered questionnaire about choice of inhalation device, training and monitoring of inhalation techniques, the interchangeability and the role of costs in the selection of inhalation devices. For each item, the median (central tendency) and interquartile ranges (degree of consensus) were calculated. Results: Experts considered that the choice of inhalation device was as important as that of active substance (very good consensus) and should be driven by ease of use (good to very good consensus) and teaching (very good consensus). Experts recommended giving oral and visual instructions (good consensus) and systematic monitoring inhalation techniques. Pulmonologists and paramedics have predominantly educational roles (very good consensus). Experts discouraged inhalation device interchangeability (good consensus) and switching for cost reasons (good to very good consensus) without medical consultation (good consensus). Conclusions: The results of this survey thus suggested that inhalation devices are as important as active substances and training and monitoring are essential in ensuring effective treatment of asthma and COPD. Inhalation device switching without medical consultation should be avoided. © 2014 Informa UK, Ltd.

Document type Article de périodique (Journal article) – Article de recherche
Publication date 2014
Language Anglais
Journal information "Expert Opinion on Drug Delivery" - Vol. 11, no. 3, p. 313-323 (2014)
Peer reviewed yes
Publisher Informa Healthcare ((United Kingdom) London)
issn 1742-5247
e-issn 1744-7593
Publication status Publié
Affiliations UCL - SSS/IREC/LUNS - Pôle pneumologie, ORL (airways) et dermatologie (skin)
UCL - (SLuc) Service de pneumologie
Links
  1. EAC Broeders Mariëlle, Vincken Walter, Corbetta Lorenzo, The ADMIT series — Issues in Inhalation Therapy. 7) Ways to improve pharmacological management of COPD: the importance of inhaler choice and inhalation technique, 10.4104/pcrj.2011.00062
  2. Cochrane Mac G., Bala Mohan V., Downs Kristen E., Mauskopf Josephine, Ben-Joseph Rami H., Inhaled Corticosteroids for Asthma Therapy, 10.1378/chest.117.2.542
  3. Laube B. L., Janssens H. M., de Jongh F. H. C., Devadason S. G., Dhand R., Diot P., Everard M. L., Horvath I., Navalesi P., Voshaar T., Chrystyn H., What the pulmonary specialist should know about the new inhalation therapies, 10.1183/09031936.00166410
  4. Michele Theresa M., Pinheiro Simone, Iyasu Solomon, The Safety of Tiotropium — The FDA's Conclusions, 10.1056/nejmp1008502
  5. Accordini Simone, Corsico Angelo G., Braggion Marco, Gerbase Margaret W., Gislason David, Gulsvik Amund, Heinrich Joachim, Janson Christer, Jarvis Deborah, Jõgi Rain, Pin Isabelle, Schoefer Yvonne, Bugiani Massimiliano, Cazzoletti Lucia, Cerveri Isa, Marcon Alessandro, de Marco Roberto, The Cost of Persistent Asthma in Europe: An International Population-Based Study in Adults, 10.1159/000338998
  6. Nowak Dennis, Berger Karin, Lippert Barbara, Kilgert Katharina, Caeser Manfred, Sandtmann Ruediger, Epidemiology and Health Economics of COPD Across Europe : A Critical Analysis, 10.2165/00151829-200504060-00003
  7. Bateman E. D., Hurd S. S., Barnes P. J., Bousquet J., Drazen J. M., FitzGerald M., Gibson P., Ohta K., O'Byrne P., Pedersen S. E., Pizzichini E., Sullivan S. D., Wenzel S. E., Zar H. J., Global strategy for asthma management and prevention: GINA executive summary, 10.1183/09031936.00138707
  8. Rabe Klaus F., Hurd Suzanne, Anzueto Antonio, Barnes Peter J., Buist Sonia A., Calverley Peter, Fukuchi Yoshinosuke, Jenkins Christine, Rodriguez-Roisin Roberto, van Weel Chris, Zielinski Jan, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease : GOLD Executive Summary, 10.1164/rccm.200703-456so
  9. Hsu CC, PARE, 12, 1 (2007)
  10. Baumann Michael H., Strange Charlie, Heffner John E., Light Richard, Kirby Thomas J., Klein Jeffrey, Luketich James D., Panacek Edward A., Sahn Steven A., Management of Spontaneous Pneumothorax, 10.1378/chest.119.2.590
  11. Delbecq AL, Group techniques for program planning: a guide to nominal group and Delphi processes (1975)
  12. Sinha Ian P., Smyth Rosalind L., Williamson Paula R., Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies, 10.1371/journal.pmed.1000393
  13. Dolovich Myrna B., Ahrens Richard C., Hess Dean R., Anderson Paula, Dhand Rajiv, Rau Joseph L., Smaldone Gerald C., Guyatt Gordon, Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines, 10.1378/chest.127.1.335
  14. Hasson Felicity, Keeney Sinead, McKenna Hugh, Research guidelines for the Delphi survey technique : Delphi survey technique, 10.1046/j.1365-2648.2000.t01-1-01567.x
  15. Plaza V, Arch Bronconeumol, 48, 189 (2012)
  16. Song WS, Respir Care, 50, 1040 (2005)
  17. Vincken Walter, Dekhuijzen Richard, Barnes Peter, The ADMIT series — Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD, 10.4104/pcrj.2009.00062
  18. Mehuys E., Van Bortel L., De Bolle L., Van Tongelen I., Annemans L., Remon J. P., Brusselle G., Effectiveness of pharmacist intervention for asthma control improvement, 10.1183/09031936.00112007
  19. Kucukarslan Suzan, Lai Steven, Dong Yannan, Al-Bassam Noor, Kim Karen, Physician beliefs and attitudes toward collaboration with community pharmacists, 10.1016/j.sapharm.2010.07.003
  20. Williams Angela E., Chrystyn Henry, Survey of pharmacists’ attitudes towards interchangeable use of dry powder inhalers, 10.1007/s11096-006-9079-6
  21. Takemura, Mitsui, Ido, Matsumoto Ma, Koyama, Inoue, Takamatsu, Itotani, Ishitoko, Suzuki, Aihara, Sakuramoto, Fukui, Kagioka, Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients, 10.2147/copd.s44022
  22. Thomas Mike, Price David, Chrystyn Henry, Lloyd Andrew, Williams Angela E, von Ziegenweidt Julie, Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control, 10.1186/1471-2466-9-1
  23. Price D., Do healthcare professionals think that dry powder inhalers can be used interchangeably? : VIEWS OF HEALTHCARE PROFESSIONALS ON INTERCHANGEABLE USE OF DRY POWDER INHALERS, 10.1111/j.1368-504x.2005.00724.x
  24. Price D., Summers M., Zanen P., Could interchangeable use of dry powder inhalers affect patients? : COULD INTERCHANGEABLE USE OF DRY POWDER INHALERS AFFECT PATIENTS?, 10.1111/j.1368-504x.2005.00720.x
  25. Vinchurkar Samir, De Backer Lieve, Vos Wim, Van Holsbeke Cedric, De Backer Jan, De Backer Wilfired, A case series on lung deposition analysis of inhaled medication using functional imaging based computational fluid dynamics in asthmatic patients: effect of upper airway morphology and comparison within vivodata, 10.3109/08958378.2011.644351
Bibliographic reference Ninane, Vincent ; Brusselle, Guy G. ; Louis, Renaud ; Dupont, Lieven ; Liistro, Giuseppe ; et. al. Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: A Delphi consensus statement. In: Expert Opinion on Drug Delivery, Vol. 11, no. 3, p. 313-323 (2014)
Permanent URL http://hdl.handle.net/2078.1/164163